2019 Agenda

On-Line Access (password and copyright protected)

Thursday, November 14th

Session 1 The Value Impact to the Patient & Caregiver
Moderator: Dr. Sara Ahmed
8:00AM – 8:15AM Opening Address Kim MacDonald
8:15AM -9:00AM Keynote Address Dr. David Cella
9:00AM – 9:15AM Q&A with ARS
9:15AM – 9:25AM The impact of routine ESAS use on overall survival: results of a population based retrospective matched cohort analysis Dr. Lisa Barbera
9:25AM – 9:30AM Q&A
9:30AM – 9:45AM How are family-reported outcomes used to benefit patients and families, health care providers, and the health care system? A scoping review Dr. Jennifer Pink
9:45AM – 9:50AM Q&A
9:50AM – 10:00AM Gaps in the management of depression symptoms screening following cancer diagnosis: a population-based analysis of prospective patient-reported outcomes Dr. Julie Hallet
10:00AM -10:05AM Q&A
10:05AM – 10:35AM BREAK
10:35AM – 10:45AM Symptom severity among cancer outpatients in the last 6 months of life: Analysis of 92,757 patient-reported symptom assessment scores Dr. Natalie Coburn
10:45AM – 10:50AM Q&A
10:50AM -11:00AM Testing the validity of the EPIC-26 for use with patients with early-stage localized prostate cancer under active surveillance Jing Jang
11:00AM -11:05AM Q&A
11:05AM – 11:15AM Patient Experience in Radiation Oncology Demetra Yannitsos
11:15AM – 11:20AM Q&A
11:20AM – 11:35AM Adolescent to adult perspectives of the cancer journey from a disease-specific and age-specific viewpoint of PROS tools in head and neck cancer Julie Deleemans & Brooke Russell
11:35AM – 11:40AM Q&A
12:00PM – 12:05PM Q&A
12:05PM – 1:05PM LUNCH
1:05PM – 1:35PM  PROS HOT TOPIC DEBATE: Disease Specific versus Generalized PROS Tools?
Question: As a priority, where should we invest our resources: disease specific or generalized tools?
Audience Pre-Poll Session Facilitator – 
Dr. Michael Brundage
Argument for disease specific tools Dr. Andrea Pusic
Argument for generalized PROS tools Dr. Lisa Barbera
Facilitator questions: 1 to each of the panel Dr. Michael Brundage
Audience Post-Poll Dr. Michael Brundage
Session 2 The Value Impact in PROS Research
Moderator: Maria Santana
1:35PM – 2:20PM Pediatric PROMIS: Extension of PROMIS to Children and Adolescents Dr. Christopher Forrest
2:20PM – 2:25PM Q&A with ARS
2:25PM – 2:35PM Baseline prevalence of Edmonton Symptom Assessment System (ESAS) scores in the general population of Ontario, Canada Victoria Delibasic
2:35PM – 2:40PM Q&A
2:40PM – 2:50PM Symptom Burden of Non-resected Pancreatic Adenocarcinoma: An analysis of 10,753 Patient-Reported Outcome Assessments Dr. Natalie Coburn
2:50PM – 2:55PM Q&A
2:55PM – 3:05PM Development and Psychometric Evaluation of the Cancer Distress Scales for Adolescent and Young Adults Dr. Elena Tsangaris
3:05PM – 3:10PM Q&A
3:10PM – 3:40PM BREAK
3:40PM – 3:50PM Patient-reported symptoms following mastectomy alone or lumpectomy plus radiation for early stage breast cancer: A cohort study Dr. Natalie Coburn
3:50PM – 3:55PM Q&A
3:55PM – 4:05PM Symptom Burden among Head and Neck Cancer Patients in the First Year after Diagnosis: Association with Primary Treatment Modality Dr. Catherine Allen-Ayodabo
4:05PM – 4:10PM Q&A
4:10PM – 4:40PM POSITION STATEMENT: Position Statements presented for audience feedback: PROs for the Patient/Caregiver & PROs Research
4:10PM – 4:20PM Present statements for Patient / Caregiver Dr. Susan Bartlett
4:20PM – 4:25PM Audience voting with ARS
4:25PM – 4:35PM Present statements for PROS Research Dr. Lisa Barbera
4:35PM – 4:40PM Audience voting with ARS
4:40PM Days End

Friday, November 15th

Session 3 The Value Impact to Administration & Health Policy
Moderator: Rick Sawatzky
8:00AM – 8:15AM Opening Address: The Every Women study and key learnings to apply to changes in Health Policy Elisabeth Baugh
8:15AM – 9:00AM Keynote Address: How can EMR data  be integrated into quality of care initiatives at the administrative level Dr. Stirling Bryan
9:00AM – 9:15AM Q & A with ARS
9:15AM – 9:25AM Using Machine Learning to Predict the  Patient-Reported Outcomes of Patients with Prostate Cancer Fatemeh Sharifi
9:25AM – 9:30AM Q&A
9:30AM – 9:40AM A pan-Canadian approach to the collection and utilization of Patient Reported Outcomes in Radiation Oncology: An initiative of the Canadian Partnership for Quality Radiotherapy Dr. Michael Brundage
9:40AM – 9:45AM Q&A
9:45AM – 9:55AM Severe Symptoms Persist for Up to One Year After Diagnosis of Stage I-III Lung Cancer: An Analysis of Province-Wide Patient Reported Outcomes Dr. Dhruvin Hirpara
9:55AM – 10:00AM Q&A
10:00AM – 10:30AM BREAK
10:30AM – 10:40AM Remote Monitoring of Treatment Toxicities Using the Canadian-Advanced Symptom Monitoring and Man-agement System (Can-ASyMS): A Feasibility Study Dr. Doris Howell
10:40AM – 10:45AM Q&A
10:45AM – 10:55AM Symptoms in the last 6 months of life for esophageal cancer patients: an analysis of patient-reported outcomes Dhruvin Hirpana
10:55AM – 11:00AM Q&A
11:00AM – 11:10AM Exploring routine use of patient reported outcomes in oncology: Using a symptom complexity score to identify a personalized dose of care Dr. Linda Watson
11:10AM – 11:15AM Q&A
11:15AM – 11:45AM PROS HOT TOPIC DEBATE: Measure for Performance using PROS – is Canada ready to implement?
Question: Should we use PROS as an accreditation measure?
Audience Pre-Poll Session Facilitator – Dr. Stirling Bryan
Argument for Dr. Andrea Pusic
Argument against CDN Steering Committee Member – Rick Sawatzky
Facilitator questions: 1 to each of the panel Dr. Stirling Bryan
Audience Post-Poll Session Facilitator – Dr. Stirling Bryan
11:45AM – 12:45PM LUNCH
Session 4 The Value Impact to the Clinician / Implementation
Moderator: Dr. Doris Howell
12:45PM – 1:30PM How can clinicians integrate PROS into Clinical care using examples on how the BREASTQ Dr. Andrea Pusic
1:30PM – 1:45PM Q&A with ARS
1:45PM- 1:55PM Suicide Risk Assessment Bryan Gascon
1:55PM – 2:00PM Q&A
2:00PM – 2:10PM The value of PROS in a multidisciplinary oncology sexual health care clinic in Calgary, AB: The Oncology and Sexuality, Intimacy and Survivorship (OASIS) Clinic Carly Sears
2:10PM – 2:15PM Q&A
2:15PM – 2:25PM Pilot implementation of a cervix cancer specific patient reported outcome measure in gynecologic oncology clinics
Dr. Jennifer Croke
2:25PM – 2:30PM Q&A
2:30PM – 2:40PM Response and intervention to elevated ESAS scores: a chart audit of gynecologic oncology clinics
Dr. Jennifer Croke
2:40PM – 2:45PM Q&A
2:45PM – 3:15PM BREAK
3:15PM – 3:25PM Integrating Digital Patient Reported Outcomes (PROs) into Standard Ambulatory Care Processes Provincially: Exploring the outcomes Dr. Linda Watson
3:25PM – 3:30PM Q&A
3:30PM – 3:40PM Integrating patient reported outcomes (PROs) in Neuroendocrine Tumors (NETs) care: an assessment of cognitive and psychological screening tools during follow-up Dr. Julie Hallet
3:40PM – 3:45PM Q&A
3:45PM – 3:55PM Prospective Outcomes and Support Initiative (POSI) for Gynecological and Head and Neck Radiotherapy Patients in British Columbia: Patient Completion and Clinician Use Dr. Clem Ho
3:55PM – 4:00PM Q&A
4:20PM – 4:50PM POSITION STATEMENT: Position Statements presented for audience feedback: Health Policy & Clinical Implementation
4:20PM – 4:30PM Present statements for PROS in Health Policy Rick Sawatzky
4:30PM – 4:35PM Audience voting with ARS
4:35PM – 4:45PM Present statements for PROS Clinical Implementation Dr. Doris Howell
4:45PM – 4:50PM Audience voting with ARS
4:50PM Days End